Structural basis for SARS-CoV-2 Nucleocapsid protein recognition by single-domain antibodies
Preprint
- 1 June 2021
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, is the most severe public health event of the twenty-first century. While effective vaccines against SARS-CoV-2 have been developed, there remains an urgent need for diagnostics to quickly and accurately detect infections. Antigen tests, particularly those that detect the abundant SARS-CoV-2 Nucleocapsid protein, are a proven method for detecting active SARS-CoV-2 infections. Here we report high-resolution crystal structures of three llama-derived single-domain antibodies that bind the SARS-CoV-2 Nucleocapsid protein with high affinity. Each antibody recognizes a specific folded domain of the protein, with two antibodies recognizing the N-terminal RNA binding domain and one recognizing the C-terminal dimerization domain. The two antibodies that recognize the RNA binding domain affect both RNA binding affinity and RNA-mediated phase separation of the Nucleocapsid protein. All three antibodies recognize highly-conserved surfaces on the Nucleocapsid protein, suggesting that they could be used to develop affordable diagnostic tests to detect all circulating SARS-CoV-2 variants.Keywords
Other Versions
- Published version: Version Frontiers in Immunology, 12, preprints
This publication has 26 references indexed in Scilit:
- Single-Domain Antibodies for the Detection of SARS-CoV-2 Nucleocapsid ProteinAnalytical Chemistry, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineThe New England Journal of Medicine, 2021
- Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 NucleocapsidMolecular Cell, 2020
- Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual FunctionsMolecular Cell, 2020
- FAST CORONAVIRUS TESTS ARE COMINGNature, 2020
- How good are my data and what is the resolution?Acta crystallographica. Section D, Structural biology, 2013
- Towards automated crystallographic structure refinement with phenix.refineActa crystallographica. Section D, Structural biology, 2012
- Features and development of CootActa crystallographica. Section D, Structural biology, 2010
- XDSActa crystallographica. Section D, Structural biology, 2010
- Nucleocapsid Protein as Early Diagnostic Marker for SARSEmerging Infectious Diseases, 2004